Psychosocial Effects of Vitiligo: A Systematic Literature Review
Open accessThe DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients with vitiligo experience reduced quality of life. OBJECTIVE: To comprehensively describe the available evidence for psychosocial burden in vitiligo. METHODS: A systematic review of observational studies and clinical trials identified using PubMed, EMBASE, Scopus, and the Cochrane databases was performed through 1 March, 2021, to assess psychosocial comorbidities in vitiligo. Two independent reviewers performed an assessment of articles and extracted data for qualitative synthesis. RESULTS: Included studies (N = 168) were published between 1979 and 1 March, 2021; 72.6% were published since 2010. Disorders including or related to depression (41 studies, 0.1-62.3%) and anxiety (20 studies, 1.9-67.9%) were the most commonly reported. The most prevalent psychosocial comorbidities were feelings of stigmatization (eight studies, 17.3-100%), adjustment disorders (12 studies, 4-93.9%), sleep disturbance (seven studies, 4.6-89.0%), relationship difficulties including sexual dysfunction (ten studies, 2.0-81.8%), and avoidance or restriction behavior (12.5-76%). The prevalence of most psychosocial comorbidities was significantly higher vs healthy individuals. Factors associated with a significantly higher burden included female sex, visible or genital lesions, age < 30 years (particularly adolescents), and greater body surface area involvement, among others. The most commonly reported patient coping strategy was lesion concealment. LIMITATIONS: Available studies were heterogeneous and often had limited details; additionally, publication bias is possible. CONCLUSIONS: The results of this systematic review show that vitiligo greatly affects psychosocial well-being. The extent of psychosocial comorbidities supports the use of multidisciplinary treatment strategies and education to address the vitiligo-associated burden of disease. PROTOCOL REGISTRATION: PROSPERO (CRD42020162223).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 Number of patients with vitiligo in included studies by country and number of studies. * Number of patients is the sum of patients across studies from each country with multiple populations from the same patient population excluded; the number of unique studies is shown in parentheses after the name of each country. † Includes three studies with populations in the USA and a European country (France, one study [n = 442]; Germany, two studies [n = 85 and n = 74]). Within each study, the number of patients in each country was not available in the published studies; thus, the full population is included in both countries on this map. ‡ Includes one study with a population in France and the USA (n = 442). The number of patients in each country was not available in the published study; thus, the full population is included in both countries on this map. § Includes two studies with populations in Germany and the USA (n = 85 and n = 74) and one study with a population in Germany and Jordan (n = 167). Within each study, the number of patients in each country was not available in the published studies; thus, the full population is included in both countries on this map. || Includes one study with a population in Jordan and Germany (n = 167). The number of patients in each country was not available in the published study; thus, the full population is included in both countries on this map](https://figures.cochat.ai/paper-figures/8cb965110057437885966dfe5152f76b/psychosocial-effects-of-vitiligo-a-systematic-literature-review-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, comorbid autoimmune disorders and mental health diagnoses can further affect wellbeing and QoL.[5][6][7][8][9]”
From Burden of disease and treatment patterns in patients with vitiligo: findings from a national longitudinal retrospective study in the UK (2024) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
FINLAY, A. Y., & KHAN, G. K. (1994) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1994.tb01167.x · Cited by 5,586
Ezzedine, K., Eleftheriadou, V., Whitton, M., & van Geel, N. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60763-7 · Cited by 943
Self-citationAutoimmune Diseases and Severe Infections as Risk Factors for Mood Disorders: A Nationwide Study
Benros, M. E., Waltoft, B. L., Nordentoft, M., Østergaard, S. D., Eaton, W. W., Krogh, J., & Mortensen, P. B. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1111 · Cited by 572
A review of the worldwide prevalence of vitiligo in children/adolescents and adults
Krüger, C., & Schallreuter, K. U. (2012) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2011.05377.x · Cited by 571
The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force
Taïeb, A., Picardo, M., & members, O. B. O. T. O. V. (2007) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00355.x · Cited by 517
Guideline for the diagnosis and management of vitiligo
Gawkrodger, D. J., Ormerod, A. D., Shaw, L., Mauri-Sole, I., Whitton, M. E., Watts, M. J., Anstey, A. V., Ingham, J., & Young, K. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08881.x · Cited by 332
Research Techniques Made Simple: Assessing Risk of Bias in Systematic Reviews
Drucker, A. M., Fleming, P., & Chan, A.-W. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.08.021 · Cited by 314
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
Rosmarin, D., Pandya, A. G., Lebwohl, M., Grimes, P., Hamzavi, I., Gottlieb, A. B., Butler, K., Kuo, F., Sun, K., Ji, T., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30609-7 · Cited by 271
Self-citationEffect of vitiligo on self-reported health-related quality of life
Ongenae, K., Van Geel, N., De Schepper, S., & Naeyaert, J. M. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06456.x · Cited by 254
Psychiatric morbidity in vitiligo: prevalence and correlates in India
Mattoo, S., Handa, S., Kaur, I., Gupta, N., & Malhotra, R. (2002) · Journal of the European Academy of Dermatology and Venereology · doi:10.1046/j.1468-3083.2002.00590.x · Cited by 222
Research works printed but not linked: 5
- Bonotis K, Pantelis K, Karaoulanis S, Katsimaglis C, Papaliaga M, Zafiriou E, et al. Investigation of factors associated with health-related quality of life and psychological distress in vitiligo. J Dtsch Dermatol Ges. 2016;14(1):45–9.
- Güler Ö, Karaca Ş, Aşik AH, Yalçin C. Psychosocial symptoms in patients with psoriasis, vitiligo, and neurodermatitis. Neurol Psychiatry Brain Res. 2009;16(3–4):139–44.
- Maghami Z, Sepaskhah M, Sarani EM, Bagheri Z, Maghami M. Alexithymia in vitiligo patients: a case-control study. Iran J Dermatol. 2018;21(4):138–41.
- Xu ST, Oh EH, Kim JE, Ko JY, Ro YS. Comparative study of quality of life between psoriasis, vitiligo and autoimmune bullous disease. Hong Kong J Dermatol Venereol. 2017;25(2):57–64.
- Ray A, Pal MK, Ghosh M, Sanyal D. Psychodermatological disorders: an assessment of psychiatric morbidity. Int Med J. 2011;18(4):300–4.
Cited by
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
Rosmarin, D., Passeron, T., Pandya, A. G., Grimes, P., Harris, J. E., Desai, S. R., Lebwohl, M., Ruer-Mulard, M., Seneschal, J., Wolkerstorfer, A., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2118828 · Cited by 316
Self-citationvan Geel, N., Speeckaert, R., Taïeb, A., Ezzedine, K., Lim, H. W., Pandya, A. G., Passeron, T., Wolkerstorfer, A., Abdallah, M., Alomar, A., et al. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19451 · Cited by 186
Self-citationBibeau, K. B., Ezzedine, K., Harris, J. E., van Geel, N., Grimes, P. E., Parsad, D., Tulpule, M. S., Gardner, J., Valle, Y., Matewa, G. T., et al. (2023) · JAMA Dermatology · doi:10.1001/jamadermatol.2023.2787 · Cited by 166
Self-citationThe humanistic burden of vitiligo: a systematic literature review of quality‐of‐life outcomes
Picardo, M., Huggins, R. H., Jones, H., Marino, R., Ogunsola, M., & Sénéschal, J. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18129 · Cited by 92
Self-citationBeyond skin white spots: Vitiligo and associated comorbidities
Hu, Z., & Wang, T. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1072837 · Cited by 84
Metadata
- Authors
- Ezzedine, K., Eleftheriadou, V., Jones, H., Bibeau, K., Kuo, F. I., Sturm, D., & Pandya, A. G.
- Affiliations
- Université Paris-Est Créteil (FR)
- Queen Elizabeth Hospital Birmingham (GB)
- Incyte (United States) (US)
- Palo Alto Medical Foundation (US)
- Corresponding author
- Ezzedine, Khaled
- ORCID
- Venue
- American Journal of Clinical Dermatology
- Published
- 2021-09-23
- Volume
- 22
- Issue
- 6
- Pages
- 757-774
- ISSN
- 1175-0561 (ISSN-L)
- 1179-1888
- PMC
- PMC8566637
- OpenAlex
- W3199110510
- Cited by
- 276
- References
- 186
- Citations by year
- 2026: 65 · 2025: 64 · 2024: 63 · 2023: 60 · 2022: 22 · 2021: 2
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0 (tdm)
- creativecommons.org/licenses/by-nc/4.0 (vor)
- Locations
- American Journal of Clinical Dermatology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Incyte Corporation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Social Sciences › Psychology › Clinical Psychology › Body Image and Dysmorphia Studies
- Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
- Keywords
- vitiligo, psychosocial burden, quality of life, depression, anxiety, stigmatization, adjustment disorder, sleep disorders, sexual dysfunction, avoidance behavior, coping strategies, body surface area involvement, risk factors
- MeSH terms
- Adaptation, Psychological, Adjustment Disorders, Age Factors, Body Surface Area, Clinical Trials as Topic, Female, Humans, Male, Personality Disorders, Quality of Life, Risk Factors, Severity of Illness Index, Vitiligo, Comorbidity, Prevalence, Social Stigma, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Psychosocial Effects of Vitiligo: A Systematic Literature Review. https://app.cochat.ai/papers/10.1007/s40257-021-00631-6
- The paper
- Ezzedine, K., Eleftheriadou, V., Jones, H., Bibeau, K., Kuo, F. I., Sturm, D., & Pandya, A. G. (2021). Psychosocial Effects of Vitiligo: A Systematic Literature Review. American Journal of Clinical Dermatology. https://doi.org/10.1007/s40257-021-00631-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.